Compound 165
Identifiers
- Canonical SMILES:
Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(F)cc1)Cc1ccc(CNS(=O)(=O)c2cc(Cl)cc(Cl)c2)cc1
- InChi:
InChI=1S/C27H21Cl4FN2O5S2/c28-20-9-21(29)11-24(10-20)40(36,37)33-14-17-1-3-18(4-2-17)15-34(16-19-5-7-23(32)8-6-19)41(38,39)26-13-22(30)12-25(31)27(26)35/h1-13,33,35H,14-16H2
- InChiKey:
OTIKOEVECJUKND-UHFFFAOYSA-N
External links
66616639 |
External search
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 98 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.64 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 675.96 g/mol | |||
HBA | 7 | |||
HBD | 2 | |||
HBA + HBD | 9 | |||
AlogP | 7.29 | |||
TPSA | 103.78 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 98 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.64 | |
WO2009152082 | 98 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.55 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6667 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.4956 | Saccharin | DB12418 | |
0.4870 | Sulfabenzamide | DB09355 | |
0.4865 | 4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide | DB02429 | |
0.4834 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.4762 | Evatanepag | DB12022 | |
0.4701 | 4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide | DB04180 | |
0.4701 | 4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide | DB02221 | |
0.4609 | N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide | DB02069 | |
0.4576 | 4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide | DB02861 | |
0.4530 | N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide | DB03844 | |
0.4508 | 4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide | DB04549 | |
0.4494 | Avagacestat | DB11893 | |
0.4472 | N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide | DB02610 | |
0.4417 | 4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide | DB03039 |